- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N), a developer of advanced nanomaterials and extended release nanotechnologies, today announced that its Director of Research and Development, Aaron Wagner, Ph.D., will present "Applications of Halloysite Nanotubes in Polymer Composites" at the Eighth World Congress Nanocomposites 2008. The presentation is Tuesday, September 16, 2008 at 5:00 p.m. Pacific, at the Crown Plaza in San Diego, CA.
For information about the Eighth World Congress Nanocomposites 2008, visit www.executive-conference.com. The Eighth World Congress is specifically designed for business executives, engineers, and scientists to gain essential and wide-ranging knowledge about the state-of-the-art of nanotechnology, especially polymeric nanocomposites. The conference runs from Monday, September 15, 2008 to Wednesday, September 17, 2008.
About NaturalNano, Inc.
NaturalNano, Inc. (www.naturalnano.com) (OTCBB: NNAN) (FWB: N3N) is a materials science company focused on developing and commercializing advanced nanocomposites and extended release nanotechnologies. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximerô polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses over 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes.
Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.
For more information, please click here
Patrick Kane, Karen Keller
Lambert, Edwards & Associates
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Soft decoupling of organic molecules on metal June 23rd, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016